New York, Aug. 3 – Morgan Stanley Finance LLC priced $5 million of 0% enhanced buffered jump securities due Aug. 30, 2024 linked to the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.
If the ETF gains or ends above the 90% downside threshold the payout at maturity will be par plus 15.4%.
Investors will lose 1.1111% for every 1% that the ETF declines beyond the 10% buffer amount.
The notes are guaranteed by Morgan Stanley.
Morgan Stanley & Co. LLC is the agent.
| Issuer: | Morgan Stanley Finance LLC
|
| Guarantor: | Morgan Stanley
|
| Issue: | Enhanced buffered jump securities
|
| Underlying ETF: | SPDR S&P Biotech ETF
|
| Amount: | $5 million
|
| Maturity: | Aug. 30, 2024
|
| Coupon: | 0%
|
| Price: | Par
|
| Payout at maturity: | If ETF finishes at or above downside threshold level, par plus 15.4%; 1.1111% loss for every 1% that ETF declines beyond the buffer amount
|
| Initial level: | $83.05
|
| Downside threshold: | $74.745, 90% of initial level
|
| Buffer: | 10%
|
| Pricing date: | July 27
|
| Settlement date: | Aug. 1
|
| Agent: | Morgan Stanley & Co. LLC
|
| Fees: | 0.75% including a structuring fee of 0.25%
|
| Cusip: | 61775HRS8
|
|
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
